Ethyl 2-(4-Boc-1-piperazinyl)acetate

Catalog No. :
ACNZCE271
CAS No. :
209667-59-4
Molecular Formula :
C13H24N2O4
Molecular Weight :
272.35

IUPAC Name:tert-butyl 4-(2-ethoxy-2-oxoethyl)piperazine-1-carboxylate

Ethyl 2-(4-Boc-1-piperazinyl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g96%$170.00Login to see priceIn stockInquiry
10g96%$339.00Login to see priceIn stockInquiry
25g96%$632.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(4-Boc-1-piperazinyl)acetate
IUPAC Nametert-butyl 4-(2-ethoxy-2-oxoethyl)piperazine-1-carboxylate
MDL No.MFCD06795955
Molecular FormulaC13H24N2O4
Molecular Weight272.35
SMILESO=C(N1CCN(CC(OCC)=O)CC1)OC(C)(C)C
InChI KeyBWRNREIEPIQCOI-UHFFFAOYSA-N
SynonymFT-0684863 | SCHEMBL1088524 | 1-PIPERAZINEACETIC ACID, 4-[(1,1-DIMETHYLETHOXY)CARBONYL]-, ETHYL ESTER | 1-BOC-4-ETHOXYCARBONYLMETHYLPIPERAZINE | tert-Butyl 4-[(ethoxycarbonyl)methyl]-piperazine-1-carboxylate | TERT-BUTYL 4-[(ETHOXYCARBONYL)METHYL]PIPERAZI
CAS No.209667-59-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACNZCE271 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFPFL382 route compound structure diagram
    ACFPFL382126231-77-4
  4. Then
  5. ACNZCE271 route product structure diagram
    ACNZCE271209667-59-4 In Stock
Inquiry

2. ACNZCE271 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNZCE271 route product structure diagram
    ACNZCE271209667-59-4 In Stock
Inquiry

Comments (0)